A Prospective Study of CD38/45 Flow Cytometry and Immunofluorescence Microscopy to Detect Blood Plasma Cells in Patients with Plasma Cell Proliferative Disorders

References

• Szczepek A J, Seeberger K, Wizniak J, Mant M J, Belch A R, Pilarski L M. A High Frequency of Circulating B Cells Share Clonotypic Ig Heavy-Chain Vdj Rearrangements With Autologous Bone Marrow Plasma Cells in Multiple Myeloma, As Measured By Single-Cell and in Situ Reverse Transcriptase Polymerase Chain Reaction. Blood 1998; 92: 2844–2855
   PubMed Web of Science ®Google Scholar
• Billadeau D, Van Ness B, Kimlinger T, Kyle R, Therneau T, Greipp P, Witzig T. Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma. Blood 1996; 88: 289–296
   PubMed Web of Science ®Google Scholar
• Rawstron A C, Owen R G, Davies F E, Johnson R J, Jones R A, Richards S J, Evans P A, Child J A, Smith G M, Jack A S, Morgan G J. Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage. Br J Haematol 1997; 97: 46–55
   PubMed Web of Science ®Google Scholar
• Witzig T, Kimlinger T, Ahmann G, Katzmann J, Greipp P. Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 1996; 26: 113–120
   PubMedGoogle Scholar
• Witzig T, Gertz M, Lust J, Kyle R, O'Fallon W, Greipp P. Peripheral blood monoclonal plasma cells as a predictor of survival in patients with multiple myeloma. Blood 1996; 88: 1780–1787
   PubMed Web of Science ®Google Scholar
• Brown R D, Luo X F, Gibson J, Brisco M, Sykes P, Morley A, Joshua D. Longitudinal analysis of circulating myeloma cells detected by allele specific mRNA in situ hybridization. Am J Hematol 1998; 58: 273–277
   PubMed Web of Science ®Google Scholar
• Cremer F W, Kiel K, Wallmeier M, Haas R, Goldschmidt H, Moos M. Leukapheresis products in multiple myeloma: lower tumor load after mobilization with cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone. Exp Hematol 1998; 26: 969–975
   PubMed Web of Science ®Google Scholar
• Harada Y, Kawano M M, Huang N, Mahmoud M S, Lisukov I A, Mihara K, Tsujimoto T, Kuramoto A. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996; 92: 184–191
   PubMed Web of Science ®Google Scholar
• Schneider U, Van Lessen A, Huhn D, Serke S. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. Br J Haematol 1997; 97: 56–64
   PubMed Web of Science ®Google Scholar
• Rawstron A, Barrens S, Blythe D, Davies F, English A, Pratt G, Child A, Morgan G, Jack A. Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression. Br J Haematol 1999; 104: 138–143
   PubMed Web of Science ®Google Scholar
• Witzig T, Gonchoroff N, Katzmann J, Themeau T, Kyle R, Greipp P. Peripheral blood B-cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol 1988; 6: 1041–1046
   PubMed Web of Science ®Google Scholar
• Witzig T, Dhodapkar M, Kyle R, Greipp P. Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 1993; 72: 108–113
   PubMed Web of Science ®Google Scholar
• Witzig T, Gertz M, Lust J, Kyle R, Greipp P. Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest. LeukLymphoma 1995; 19: 417–422
   PubMed Web of Science ®Google Scholar
• Gertz M A, Witzig T E, Pineda A A, Greipp P R, Kyle R A, Litzow M R. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation. Bone Marrow Transplant 1997; 19: 337–342
   PubMed Web of Science ®Google Scholar
• Billadeau D, Prosper F, Verfaillie C, Weisdorf D, Van Ness B. Sequential analysis of bone marrow and peripheral blood after stem cell transplant for myeloma shows disparate tumor involvement. Leukemia 1997; 11: 1565–1570
   PubMed Web of Science ®Google Scholar
• Corradini P, Voena C, Tarella C, Astolfi M, Ladetto M, Palumbo A, Van Lint M T, Bacigalupo A, Santoro A, Musso M, Majolino I, Boccadoro M, Piled A. Molecular and clinical remissions in multiple myeloma: Role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol 1999; 17: 208–215
   PubMed Web of Science ®Google Scholar
• Kiel K, Cremer F W, Rottenburger C, Kallmeyer C, Ehrbrecht E, Atzberger A, Hegenbart U, Goldschmidt H, Moos M. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 23: 1019–1027
   PubMed Web of Science ®Google Scholar
• Witzig T, Kyle R, O'Fallon W, Greipp P. Detection of peripheral blood plasma cells as a predictor of disease course in patients with smoldering multiple myeloma. Br J Haematol 1994; 87: 266–272
   PubMed Web of Science ®Google Scholar